FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer

BACKGROUND: Pancreatic Cancer is one of the most lethal cancers, with less than 8% of patients surviving 5 years following diagnosis. The last 40 years have seen only small incremental improvements in treatment options, highlighting the continued need to better define the cellular and molecular path...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidson, Catherine, Taggart, David, Sims, Andrew H., Lonergan, David W., Canel, Marta, Serrels, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643373/
https://www.ncbi.nlm.nih.gov/pubmed/36138073
http://dx.doi.org/10.1038/s41416-022-01966-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643373/
https://www.ncbi.nlm.nih.gov/pubmed/36138073
http://dx.doi.org/10.1038/s41416-022-01966-5

Ejemplares similares